Effects of oral albuterol on serum lipids and carbohydrate metabolism in healthy men

Metabolism: Clinical and Experimental

Volumn 45, Issue 6, 1996, Pages 712-717

  Maki, Kevin C ^c   Skorodin, Morton S ^a,b   Jessen, Jill H ^d   Laghi, Franco ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c RADIANT RESEARCH   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SALBUTAMOL;

ADULT; ANTHROPOMETRY; ARTICLE; ASTHMA; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RESPONSE; LIPOPROTEIN BLOOD LEVEL; LUNG FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0029887287     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90136-5     Document Type: Article

References (37)

1. Kim YS, Sainz RD: B-Adrenergic agonists and hypertrophy of skeletal muscles. Life Sci 50:397-407, 1992
2. Yang YT, McElligott MA: Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue. Biochem J 261:1-10, 1989
3. Maltin CA, Delday MI, Watson JL, et al: Clenbuterol, a β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci 84:651-654, 1993
4. Signorile JF, Banovac K, Gomez M, et al: Increased muscle strength in paralyzed patients after spinal cord injury: Effect of beta-2 adrenergic agonist. Arch Phys Med Rehabil 76:55-58, 1995
5. Bressler P, DeFronzo RA: Drugs and diabetes. Diabetes Rev 2:53-84, 1994
6. 2-agonists. J Clin Pharm Ther 17:155-164, 1992
7. 2-adrenoceptor agonists salbutamol and rimiterol. Br J Pharmacol 9:483-491, 1980
8. Skorodin MS, Freebeck PC, Yetter B, et al: Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline. Chest 105:701-705, 1994
9. Tantucci C, Santeusanio F, Beschi M, et al: Metabolic and hormonal effects of preferential beta 1- and beta 2-adrenoreceptor stimulation in man. J Endocrinol Invest 11:279-287, 1988
10. Lukaski HC, Johnson PE, Bolunchuk WW, et al: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 47:7-14, 1988
11. Bergman RN, Ader M: Concepts emerging from the minimal model approach. Curr Top Diabetes Res 12:39-65, 1993
12. Anderson RL, Hamman RF, Savage PJ, et al: Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance tests. Am J Epidemiol 142:724-732, 1995
13. Kahn SE, Prigeon R, McColloch DK, et al: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Diabetes 42:1663-1672, 1993
14. Hooper PL, Woo W, Visconti L, et al: Terbutaline raises high-density-lipoprotein-cholesterol levels. N Engl J Med 305:1455-1457, 1981
15. Chazan R, Droszcz W, Bobilewicz D, et al: Changes in plasma high density lipoprotein (HDL) levels after salbutamol. Int J Clin Pharmacol Ther Toxicol 23:427-429, 1985
16. Lithell HO: Effects of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14:203-209, 1991
17. 2-agonism improves glucose and lipid metabolism in essential hypertension. Metabolism 43:455-461, 1994
18. Herrmann JM, Mayer EO: A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors. II. Am Heart J 116:1416-1421, 1988
19. Materson BJ, Vlachakis ND, Glasser SP, et al: Influence of beta2 agonism and betal and beta2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprolol. Am J Cardiol 63:58-63, 1989
20. Ward KD, Sparrow D, Landsberg L, et al: The relationship of epinephrine excretion to serum lipid levels: The Normative Aging Study. Metabolism 43:509-513, 1994
21. Thompson FE, Byers T: Dietary Assessment Resource Manual. J Nutr 124:2245S-2317S, 1994 (suppl)
22. Dzau VJ, Sacks FM: Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol 10:S2-S6, 1987 (suppl)
23. Tall A: Plasma high-density lipoproteins: Metabolism and relationship to atherogenesis. J Clin Invest 86:379-384, 1990
24. 2-adrenergic agonist clenbuterol. Can J Physiol Pharmacol 70:1555-1562, 1992
25. Wager J, Lunell NO, Nadal M, et al: Glucose tolerance following oral salbutamol treatment in late pregnancy. Acta Obstet Gynecol Scand 60:291-294, 1981
26. Morrow LA, Morganroth GS, Herman WH, et al: Effects of epinephrine on insulin secretion and action in humans. Interaction with aging. Diabetes 42:307-315, 1993
27. Tibaldi JM, Lorber DL, Nerenberg A: Diabetic ketoacidosis and insulin resistance with subcutaneous terbutaline infusion: A case report. Am J Obstet Gynecol 163:509-510, 1990
28. Walters JM, Ward GM, Kalfas A, et al: The effect of epinephrine on glucose-mediated and insulin-mediated glucose disposal in insulin-dependent diabetes. Metabolism 41:671-677, 1992
29. 2 receptors. Diabetologia 29:409-416, 1986
30. Jenne JW, Chick TW, Strickland RD, et al: Subsensitivity of beta responses during therapy with a long-acting beta-2 preparation. J Allergy Clin Immun 59:383-390, 1977
31. Martin IK, Weber KM, Boston RC, et al: Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs. Am J Physiol 255:E668-E673, 1988
32. Scheidegger K, Robbins DC, Danforth E: Effects of chronic beta receptor stimulation on glucose metabolism. Diabetes 33:1144-1149, 1984
33. Lipworth BJ, Clark RA, Dhillon DP, et al: Single dose and steady state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma. Eur J Clin Pharmacol 37:49-52, 1989
34. Nolte L, Gulve EA, Holloszy JO: Epinephrine-induced in vivo muscle glycogen depletion enhances insulin sensitivity of glucose transport. J Appl Physiol 76:2054-2058, 1994
35. Acheson KJ, Ravussin E, Schoeller DA, et al: Two-week stimulation or blockade of the sympathetic nervous system in man: Influence on body weight, body composition, and twenty-four-hour energy expenditure. Metabolism 37:91-98, 1988
36. Bioelectrical Impedance Analysis in Body Composition Measurement. NIH Technology Assessment Statement. Bethesda, MD, NIH, December 12-14, 1994, pp 1-35
37. 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci 83:615-621, 1992